Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protara Therapeutics (TARA) Change in Acquisitions & Divestments (2016 - 2026)

Protara Therapeutics' Change in Acquisitions & Divestments history spans 11 years, with the latest figure at $29.1 million for Q1 2026.

  • Quarterly Change in Acquisitions & Divestments rose 288.48% to $29.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $86.9 million through Mar 2026, up 163.24% year-over-year, with the annual reading at $65.2 million for FY2025, 34.23% up from the prior year.
  • Change in Acquisitions & Divestments came in at $29.1 million for Q1 2026, down from $35.8 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $35.8 million in Q4 2025 to a low of $3.0 million in Q2 2024.
  • The 5-year median for Change in Acquisitions & Divestments is $18.5 million (2022), against an average of $17.0 million.
  • Year-over-year, Change in Acquisitions & Divestments plummeted 86.58% in 2024 and then surged 288.48% in 2026.
  • Protara Therapeutics' Change in Acquisitions & Divestments stood at $10.8 million in 2022, then skyrocketed by 34.64% to $14.5 million in 2023, then skyrocketed by 54.98% to $22.5 million in 2024, then surged by 59.22% to $35.8 million in 2025, then decreased by 18.67% to $29.1 million in 2026.
  • Per Business Quant, the three most recent readings for TARA's Change in Acquisitions & Divestments are $29.1 million (Q1 2026), $35.8 million (Q4 2025), and $17.9 million (Q3 2025).